We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

108 hedge funds and large institutions have $452M invested in MaxCyte in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

41% more capital invested

Capital invested by funds: $321M → $452M (+$131M)

34% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 29

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

6% more funds holding

Funds holding: 102 → 108 (+6)

1.44% more ownership

Funds ownership: 66.98% → 68.42% (+1.4%)

Holders
108
Holders Change
+6
Holders Change %
+5.88%
% of All Funds
1.86%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
18
Increased
39
Reduced
29
Closed
11
Calls
$99K
Puts
–
Net Calls
+$99K
Net Calls Change
+$14K

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$18M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.08M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.43M
4
BlackRock
BlackRock
New York
+$4.38M
5
Swedbank
Swedbank
Sweden
+$3.9M

Top Sellers

1
CC
Casdin Capital
New York
-$18M
2
Millennium Management
Millennium Management
New York
-$5.19M
3
Goldman Sachs
Goldman Sachs
New York
-$4.65M
4
RI
RTW Investments
New York
-$3.65M
5
Citigroup
Citigroup
New York
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Casdin Capital
New York
$69.8M -$18M -3,235,548 -23%
BlackRock
2
BlackRock
New York
$41.9M +$4.38M +784,524 +14%
VP
3
Vitruvian Partners
United Kingdom
$32.8M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$30.3M +$7.08M +1,269,810 +37%
BWLSA
5
Blue Water Life Science Advisors
California
$21M +$18M +3,225,000 New
Holocene Advisors
6
Holocene Advisors
New York
$19.8M – – –
Massachusetts Financial Services
7
Massachusetts Financial Services
Massachusetts
$16.5M +$974K +174,625 +7%
BAMCO Inc
8
BAMCO Inc
New York
$14.7M -$687K -123,209 -5%
ACH
9
ArrowMark Colorado Holdings
Colorado
$14.5M +$412K +73,862 +3%
RGI
10
River Global Investors
United Kingdom
$11.9M -$2.18M -391,387 -17%
State Street
11
State Street
Massachusetts
$11.4M +$1.06M +189,814 +12%
American Century Companies
12
American Century Companies
Missouri
$10.9M +$37.4K +6,702 +0.4%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$10.2M +$4.43M +794,469 +102%
Morgan Stanley
14
Morgan Stanley
New York
$9.68M -$366K -65,599 -4%
Millennium Management
15
Millennium Management
New York
$9.26M -$5.19M -930,751 -40%
Swedbank
16
Swedbank
Sweden
$9.1M +$3.9M +700,000 +100%
FLAM
17
First Light Asset Management
Minnesota
$8.86M +$240K +43,054 +3%
Artisan Partners
18
Artisan Partners
Wisconsin
$8.26M -$32.2K -5,768 -0.5%
PC
19
Pier Capital
Connecticut
$8.21M -$573K -102,769 -8%
GPGA
20
Grandeur Peak Global Advisors
Utah
$7.84M +$134K +23,997 +2%
Citadel Advisors
21
Citadel Advisors
Florida
$7.55M -$943K -169,068 -13%
SAM
22
Silvercrest Asset Management
New York
$6.21M -$144K -25,881 -3%
MAM
23
Montanaro Asset Management
United Kingdom
$6.01M – – –
Citigroup
24
Citigroup
New York
$5.43M -$2.94M -527,085 -39%
Northern Trust
25
Northern Trust
Illinois
$4.89M +$776K +139,212 +23%
1
2 3 4 5

MXCT Hedge Fund Activity: Q3 2022 in Review

108 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2022, worth a combined $452M — up 41% from $321M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new MXCT positions and 11 closed out — a net gain of 7 holders — while 39 added to existing stakes and 29 trimmed.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $18M. The largest seller was Casdin Capital, cutting an estimated $18M.

  • 108 institutional investors held MaxCyte (MXCT) as of Q3 2022, up from 102 in Q2 2022.
  • Funds reported $452M of MaxCyte stock for Q3 2022, up 41% quarter-over-quarter.
  • 18 funds opened new MaxCyte positions in Q3 2022 and 11 closed out, a net change of +7 holders.
  • The largest MaxCyte buyer in Q3 2022 was Blue Water Life Science Advisors, an estimated $18M added.
  • The largest MaxCyte seller in Q3 2022 was Casdin Capital, an estimated $18M sold.

Based on aggregated 13F filings for Q3 2022.